Cytek Legal Monday, August 24, 2026 0.00 Neutral

Jury Rules in Favor of Cytek on Majority of Patent Claims

Cytek Biosciences, Inc. prevailed in a Delaware district court jury trial against Beckman Coulter for three of four patent claims regarding assertion of noninfringement and invalidity, though a finding on doctrine of equivalents and a $56M damages award remain.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day